Research News

The U.S. Food and Drug Administration today approved Cyramza (ramucirumab) to treat patients with advanced stomach cancer or gastroesophageal junction adenocarcinoma, a... Read More

Changes in long noncoding RNA-AA174084 levels in the tissues, gastric juice and plasma of patients with gastric cancer were associated with clinicopathological... Read More

Over the past few years, the scientific community has become more and more interested in the “microbiome”-the 100 trillion or so bacteria... Read More

It has long been known that Helicobacter pylori infection can be a risk factor for gastric cancer, but what’s not known is... Read More

INDIANAPOLIS, Sept. 26, 2013 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) today announced top-line results from two global Phase III studies... Read More

In the September issue of Gastroenterology, researchers from Centre for Computational Biology at Duke-National University of Singapore Graduate Medical School identified three... Read More

CAMBRIDGE, Mass., July 22, 2013 (GLOBE NEWSWIRE) — Merrimack Pharmaceuticals, Inc. (Nasdaq:MACK) today announced the enrollment of its first patient in a... Read More

For patients with advanced gastric cancer, treatment with chemotherapy after surgery can reduce the risk of cancer related death by 34% over... Read More

Researchers at Leiden University Medical Center, The Netherlands, have clarified the role of lymph node dissection in gastric cancer by comparing two... Read More

In Asia, a Phase II study conducted at Seoul National University Hospital, South Korea showed positive data in heavily pretreated people with... Read More